COH Cochlear Ltd
- 323.510
- -3.140-0.96%
Cochlear Ltd News
Cochlear Limited's (ASX:COH) Stock Been Rising: Are Strong Financials Guiding The Market?
AU Evening Wrap: ASX Rally Late to Close Flat; Fletcher Plummets 11%
Consumer and health stocks were the best performers as the benchmark index rallied from almost 0.4% down over the last hour of Monday's session.
$20,000 Invested in These ASX 200 Shares 10 Years Ago Is Worth...
To demonstrate just how successful this investment strategy can be with ASX 200 shares, I like to look at how much a single $20,000 investment in certain shares 10 years ago would be worth today.
AU Evening Wrap: Australia Shares Rise 0.7%, Led by Real-Estate Stocks
Property trusts were the best performing sector, rising 1.8%.
Cochlear (ASX:COH) May Have Issues Allocating Its Capital
Institutions Along With Retail Investors Who Hold Considerable Shares InCochlear Limited (ASX:COH) Come Under Pressure; Lose 3.3% of Holdings Value
Cochlear's Acquisition of Oticon Unlikely to Lessen Implants Competition, ACCC Says
Cochlear's Acquisition of Oticon Unlikely to Lessen Implants Competition, ACCC Says
ACCC: Cochlear's Acquisition No Longer Includes Bone Conduction Solutions
ACCC: Cochlear's Acquisition No Longer Includes Bone Conduction Solutions
Australian Competition Regulator Approves Cochlear's Oticon Acquisition
Australian Competition Regulator Approves Cochlear's Oticon Acquisition
Investing in Cochlear (ASX:COH) Five Years Ago Would Have Delivered You a 104% Gain
Cochlear Stock Not Priced for Potential Vaccine Risks -- Market Talk
0241 GMT - Cochlear's share price doesn't seem to reflect risks, including from the potential launch of a vaccine against newborn hearing impairment, Morgan Stanley analyst Sean Laaman says. He thinks
AU Morning Wrap: Australia Shares Lift; Gold Reaches Record High
Stocks to watch: Washington H Soul Pattinson, Brickworks, Sigma Healthcare, Electro Optic Systems.
Cochlear Price Target Cut 7.2% to A$256.00/Share by Morgan Stanley
Cochlear Price Target Cut 7.2% to A$256.00/Share by Morgan Stanley
Cochlear Ltd's Dividend Analysis
Should You Be Adding Cochlear (ASX:COH) To Your Watchlist Today?
Morgan Stanley Adjusts Cochlear's Price Target to AU$276 From AU$258, Keeps at Underweight
09:27 PM EST, 03/05/2024 (MT Newswires) -- Morgan Stanley Adjusts Cochlear's Price Target to AU$276 From AU$258, Keeps at Underweight Price (AUD): $336.10, Change: $+1.02, Percent Change: +0.31%
ASX Weekly Report for 19 Feb to 23 Feb 2024
In the coming week we have earnings reports from Coles and Woodside (Tues), Suncorp (Mon), Worley (Wed), Harvey Norman, Ramsay Health Care (Thur).
Cochlear's Valuation Implies Unrealistic Implant Growth -- Market Talk
0244 GMT - Cochlear's current valuation implies hearing-implant sales or operating leverage well in excess of company targets, Macquarie analysts write in a note. They tell clients that implant sale v
How These 4 ASX 200 Shares Just Gained Major Broker Upgrades
Four S&P/ASX 200 Index (ASX: XJO) shares have just gained some sizeable upgrades from leading brokers.
Cochlear's Buyback Pause Suggests Stock Is Expensive -- Market Talk
0225 GMT - Cochlear's decision to pause its share buyback suggests that management see the stock as expensive, Citi analyst Mathieu Chevrier writes in a note. He maintains a sell rating on the stock,
Analysis
Price Target
No Data
